Clinical Trial Update: Effects of Saxagliptin on Adipose Tissue Inflammation in Humans [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining saxagliptin's effects on adipose tissue inflammation in humans with type 2 diabetes mellitus has completed. The sponsor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Onglyza (Saxagliptin)

Snippet

Sponsor: Phoenix VA Health Care System | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Status: COMPLETED